ArticleOncoimmunology2016

The association of clinical outcome and peripheral T-cell subsets in metastatic colorectal cancer patients receiving first-line FOLFIRI plus bevacizumab therapy.

Mario Roselli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.